13F-HR filed by TCG Crossover Management, LLC
TCG Crossover Management, LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 21 holding rows worth $333,401,000.
- Accession
- 0001214659-22-013609
- Filer
- CIK 1839948
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 21 entries on the cover page, a total value of $333,401,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $333,401,000 with VALUE read as thousands by filing date, 13F file number 028-22283. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IVERIC BIO INC | 46583P102 | COM | 3,877,903 | $69,570,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 3,481,042 | $51,937,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 12,115,926 | $28,351,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,164,000 | $23,874,000 | thousands by filing date | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 2,104,875 | $21,122,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 5,905,400 | $20,669,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,348,642 | $18,422,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,144,939 | $18,021,000 | thousands by filing date | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 959,572 | $15,910,000 | thousands by filing date | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 642,189 | $10,121,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 1,643,500 | $10,058,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 1,350,006 | $9,126,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 945,707 | $8,313,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 1,000,000 | $7,760,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 300,000 | $6,009,000 | thousands by filing date | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,172,250 | $4,244,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 2,124,122 | $2,995,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 72,777 | $2,489,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 30,000 | $1,950,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 254,569 | $1,833,000 | thousands by filing date | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 555,000 | $627,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-22-013609 | this filing | 2022-11-14 | acceptance time not in the bulk data set |